130 related articles for article (PubMed ID: 23866907)
1. Genetic testing of sperm donors for cystic fibrosis and spinal muscular atrophy: evaluation of clinical utility.
Landaburu I; Gonzalvo MC; Clavero A; Ramirez JP; Yoldi A; Mozas J; Zamora S; Martinez L; Castilla JA
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):183-7. PubMed ID: 23866907
[TBL] [Abstract][Full Text] [Related]
2. Spinal muscular atrophy (SMA) after conception using gametes from anonymous donors: recommendations for the future.
Callum P; Urbina MT; Falk RE; Alvarez-Diaz JA; Benjamin I; Sims CA
Fertil Steril; 2010 Feb; 93(3):1006.e1-2. PubMed ID: 19962137
[TBL] [Abstract][Full Text] [Related]
3. Outcome and experience of implementing spinal muscular atrophy carrier screening on sperm donors.
Callum P; Iger J; Ray M; Sims CA; Falk RE
Fertil Steril; 2010 Oct; 94(5):1912-4. PubMed ID: 20152968
[TBL] [Abstract][Full Text] [Related]
4. Spinal muscular atrophy: a time for screening.
Prior TW
Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691
[TBL] [Abstract][Full Text] [Related]
5. A 10-year large-scale cystic fibrosis carrier screening in the Italian population.
Picci L; Cameran M; Marangon O; Marzenta D; Ferrari S; Frigo AC; Scarpa M
J Cyst Fibros; 2010 Jan; 9(1):29-35. PubMed ID: 19897426
[TBL] [Abstract][Full Text] [Related]
6. Carriers of cystic fibrosis among sperm donors: complete CFTR gene analysis versus CFTR genotyping.
Molina M; Yoldi A; Navas P; Gañán M; Vaquero Á; Del Pico JL; Ramírez JP; Castilla JA
Fertil Steril; 2020 Sep; 114(3):524-534. PubMed ID: 32773111
[TBL] [Abstract][Full Text] [Related]
7. [Molecular diagnosis of spinal muscular atrophy by multiplex ligation-dependent probe amplification].
Zeng J; Ke LF; Deng XJ; Cai MY; Tu XD; Lan FH
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3262-4. PubMed ID: 19159550
[TBL] [Abstract][Full Text] [Related]
8. Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy.
Mouawia H; Saker A; Jais JP; Benachi A; Bussières L; Lacour B; Bonnefont JP; Frydman R; Simpson JL; Paterlini-Brechot P
Reprod Biomed Online; 2012 Nov; 25(5):508-20. PubMed ID: 23000084
[TBL] [Abstract][Full Text] [Related]
9. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
10. Genetic testing of sperm donors: survey of current practices.
Sims CA; Callum P; Ray M; Iger J; Falk RE
Fertil Steril; 2010 Jun; 94(1):126-9. PubMed ID: 19342039
[TBL] [Abstract][Full Text] [Related]
11. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative analysis of the genes determining spinal muscular atrophy].
Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis for risk of spinal muscular atrophy.
Cuscó I; Barceló MJ; Soler C; Parra J; Baiget M; Tizzano E
BJOG; 2002 Nov; 109(11):1244-9. PubMed ID: 12452462
[TBL] [Abstract][Full Text] [Related]
14. Human Genetics Society of Australasia position statement: population-based carrier screening for cystic fibrosis.
Delatycki MB; Burke J; Christie L; Collins F; Gabbett M; George P; Haan E; Ioannou L; Martin N; McKenzie F; O'Leary P; Scoble-Williams N; Turner G; Massie J;
Twin Res Hum Genet; 2014 Dec; 17(6):578-83. PubMed ID: 25431289
[TBL] [Abstract][Full Text] [Related]
15. SMN1 dosage analysis in spinal muscular atrophy from India.
Kesari A; Rennert H; Leonard DG; Mittal B
BMC Med Genet; 2005 May; 6():22. PubMed ID: 15910686
[TBL] [Abstract][Full Text] [Related]
16. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
18. Carrier screening for spinal muscular atrophy with a simple test based on melting analysis.
Xia Z; Zhou Y; Fu D; Wang Z; Ge Y; Ren J; Guo Q
J Hum Genet; 2019 May; 64(5):387-396. PubMed ID: 30765868
[TBL] [Abstract][Full Text] [Related]
19. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
[TBL] [Abstract][Full Text] [Related]
20. Rapid prenatal diagnosis of spinal muscular atrophy by denaturing high-performance liquid chromatography system.
Shaw SW; Cheng PJ; Chang SD; Lin YT; Hung CC; Chen CP; Su YN
Acta Obstet Gynecol Scand; 2008; 87(9):960-8. PubMed ID: 18720039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
